Chiba, Japan

Kiyonori Umekawa

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignee: Kureha Chemical Industry Company, Limited. Active years: 1995-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kiyonori Umekawa. Retrieved from https://idiyas.com/inventor/kiyonori-umekawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 1995-2003

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kiyonori Umekawa: Innovator in Chondroprotective Agents

Introduction

Kiyonori Umekawa is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of chondroprotective agents, holding a total of 4 patents. His work focuses on developing compounds that protect cartilage and treat arthropathy.

Latest Patents

One of his latest patents involves a chondroprotective agent comprising a flavonoid compound of a specific general formula. This compound is designed to inhibit proteoglycan depletion from the chondrocyte matrix, showcasing its effectiveness in protecting cartilage. The invention is particularly relevant for treating various arthropathies, making it a valuable contribution to medical science.

Career Highlights

Kiyonori Umekawa is associated with Kureha Chemical Industry Company, Limited, where he continues to innovate in the field of biochemistry. His research and development efforts have led to advancements that benefit patients suffering from joint-related conditions.

Collaborations

He has collaborated with notable colleagues such as Koju Watanabe and Koichi Niimura, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Kiyonori Umekawa's work in developing chondroprotective agents highlights his commitment to improving healthcare through innovative solutions. His contributions are paving the way for advancements in the treatment of arthropathy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…